Literature DB >> 24148891

Epidemiology, aetiology and management of visual impairment in children.

Ameenat Lola Solebo1, Jugnoo Rahi.   

Abstract

An estimated 19 million of the world's children are visually impaired, while 1.4 million are blind. Using the UK as a model for high income countries, from a population-based incidence study, the annual cumulative incidence of severe visual impairment/blindness (SVL/BL) is estimated to be 6/10 000 by age 15 years, with the incidence being highest in the first year of life. The population of visually impaired children within high, middle and lower income countries differ considerably between and within countries. The numerous and mainly uncommon disorders which can cause impaired vision result in heterogeneous population which includes a substantial proportion (for SVI/BL, the majority) of children with additional systemic disorders or impairments whose needs differ substantially from those with isolated vision impairment. Paediatricians and other paediatric professionals have a key role in early detection and multidisciplinary management to minimise the impact of visual impairment (VI) in childhood.

Entities:  

Keywords:  Blindness/Epidemiology; Child; Low/Epidemiology; Vision; Vision Disorders

Mesh:

Year:  2013        PMID: 24148891     DOI: 10.1136/archdischild-2012-303002

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  26 in total

Review 1.  One size doesn't fit all: time to revisit patient-reported outcome measures (PROMs) in paediatric ophthalmology?

Authors:  V Tadić; J S Rahi
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

2.  Validation of Peek Acuity application in pediatric screening programs in Paraguay.

Authors:  Bryce de Venecia; Yasmin Bradfield; Ralph Møller Trane; Alicia Bareiro; Miguel Scalamogna
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

3.  Prevalence of cerebral palsy, intellectual disability, hearing loss, and blindness, National Health Interview Survey, 2009-2016.

Authors:  Dana Olzenak McGuire; Lin H Tian; Marshalyn Yeargin-Allsopp; Nicole F Dowling; Deborah L Christensen
Journal:  Disabil Health J       Date:  2019-01-23       Impact factor: 2.554

4.  Effect of anti-VEGF treatment on retinopathy of prematurity in Zone II Stage 3.

Authors:  Xiu-Mei Yang; Yue-Xiang Zhao; Zong-Hua Wang; Lu Liu
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

5.  The impact of late-treated pediatric cataract on intraocular pressure.

Authors:  Itay Ben-Zion; Daphna Prat
Journal:  Int Ophthalmol       Date:  2021-01-20       Impact factor: 2.031

Review 6.  Magnitude and Temporal Trends in Avoidable Blindness in Children (ABC) in India.

Authors:  Venkata S Murthy Gudlavalleti
Journal:  Indian J Pediatr       Date:  2017-06-23       Impact factor: 1.967

7.  Visual Function and Neuropsychological Profile in Children with Cerebral Visual Impairment.

Authors:  Federica Morelli; Giorgia Aprile; Chiara Martolini; Elena Ballante; Lucrezia Olivier; Elisa Ercolino; Eleonora Perotto; Sabrina Signorini
Journal:  Children (Basel)       Date:  2022-06-19

8.  A new visual acuity test on touchpad for vision screening in children.

Authors:  Elsa Di Foggia; Noémie Stoll; Hélène Meunier; Adam Rimelé; Pascal Ance; Pierre-Henri Moreau; Claude Speeg-Schatz; Arnaud Sauer
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

9.  Emerging trends in childhood blindness and ocular morbidity in India: the Pavagada Pediatric Eye Disease Study 2.

Authors:  Vasudha Kemmanu; Subramanya K Giliyar; Bhujanga K Shetty; Arvind Kumar Singh; Govindasamy Kumaramanickavel; Catherine A McCarty
Journal:  Eye (Lond)       Date:  2018-06-11       Impact factor: 3.775

10.  Exploring the feasibility of delivering standardized genomic care using ophthalmology as an example.

Authors:  Niall Davison; Katherine Payne; Martin Eden; Marion McAllister; Stephen A Roberts; Stuart Ingram; Graeme C M Black; Georgina Hall
Journal:  Genet Med       Date:  2017-03-16       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.